4.5 Article

The association of chiral characteristic with drug withdrawal due to safety: A comparative analysis

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials

Simon D. Harding et al.

Summary: The IUPHAR/BPS Guide to PHARMACOLOGY has expanded its content in the past two years, focusing on infection, malaria, and antibiotic resistance. It has included a new family of Coronavirus proteins and collaborated with Medicines for Malaria Venture and AntibioticDB to enhance coverage of malaria pharmacology and antibacterials.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

NCATS Inxight Drugs: a comprehensive and curated portal for translational research

Vishal B. Siramshetty et al.

Summary: The United States has a complex regulatory scheme for marketing drugs. NCATS has developed Inxight Drugs, a web resource that integrates data from FDA, US government publications, and other sources to provide a wealth of manually curated literature data on drug ingredients and regulatory status. The database contains over 125,000 product ingredients, including approved, marketed, and investigational drugs, and is regularly updated using automated data aggregation tools.

NUCLEIC ACIDS RESEARCH (2022)

Review Chemistry, Medicinal

Chiral Switch: Between Therapeutical Benefit and Marketing Strategy

Gabriel Hancu et al.

Summary: The chirality of pharmaceutical substances is crucial in drug research as it governs the interaction between enantiomers and chiral biological targets. Use of a single pure enantiomer can enhance the effectiveness and safety of treatment. The pharmaceutical industry is currently focused on either switching previously used racemates to their single enantiomer version or developing new enantiopure drugs.

PHARMACEUTICALS (2022)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Drug-induced liver injury

Raul J. Andrade et al.

JOURNAL OF HEPATOLOGY (2019)

Review Chemistry, Medicinal

Chirality as an Important Factor for the Development of New Antiepileptic Drugs

Michal Abram et al.

CHEMMEDCHEM (2019)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Editorial Material Medicine, General & Internal

Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness

Jacqueline Corrigan-Curay et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Review Pharmacology & Pharmacy

Factors affecting the development of adverse drug reactions (Review article)

Muaed Jamal Alomar

SAUDI PHARMACEUTICAL JOURNAL (2014)

Review Biochemistry & Molecular Biology

The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution

Eva Choong et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)

Article Public, Environmental & Occupational Health

Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information

Andras Inotai et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)

Review Toxicology

Chiral Toxicology: It's the Same Thing...Only Different

Silas W. Smith

TOXICOLOGICAL SCIENCES (2009)

Editorial Material Biochemistry & Molecular Biology

First do no harm - Improving drug safety through legislation and independent research

Mark Greener

EMBO REPORTS (2008)

Review Toxicology

Role of metabolism in drug-induced idiosyncratic hepatotoxicity

JL Walgren et al.

CRITICAL REVIEWS IN TOXICOLOGY (2005)

Review Biotechnology & Applied Microbiology

Putting chirality to work: The strategy of chiral switches

I Agranat et al.

NATURE REVIEWS DRUG DISCOVERY (2002)

Article Clinical Neurology

New Single-Isomer Compounds on the Horizon

Joseph Gal

CNS SPECTRUMS (2002)